Re­searchers inch clos­er in ef­fec­tive­ly (and non-tox­i­cal­ly) mar­ry­ing CRISPR and CAR-T

CAR-T ther­a­pies tra­di­tion­al­ly have been made us­ing virus vec­tors, such as lentivirus or γ-retro­virus, to trans­fer the en­gi­neered can­cer-tar­get­ing re­cep­tor gene to a pa­tient’s T …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER